VIMGF (Vimian Group AB) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


VIMGF Vimian Group AB VIMGF
76 GF Score
Price $2.77
GF Value $3.24
! 2 Warning Signs
View Full Analysis

What is Vimian Group AB Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Vimian Group AB's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


VIMGF vs TMO, DHR, IDXX: Margin of Safety % (DCF FCF Based) Comparison

For the Diagnostics & Research subindustry, Vimian Group AB's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimian Group AB Margin of Safety % (DCF FCF Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Vimian Group AB's Margin of Safety % (DCF FCF Based) falls into.


VIMGF
76GF Score
Vimian Group AB VIMGF
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vimian Group AB (VIMGF) Overvalued in 2026?

Based on GuruFocus' analysis, Vimian Group AB stock appears to be undervalued. The current stock price of $2.77 is trading 14.5% below its estimated GF Value™ of $3.24.

Key valuation signals for VIMGF:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $3.24 vs. price of $2.77 (14.5% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the VIMGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vimian Group AB Business Description

Address Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
76GF Score

Get the complete analysis for VIMGF

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.77
Price
$3.24
GF Value